Egalet's rise continues after abuse-deterrence data

Egalet Corp. (NASDAQ:EGLT) rose $2.43 (40%) to $8.54 on Friday, a day after reporting that 60 mg Egalet-001 had significantly lower abuse potential compared to a marketed morphine tablet. Egalet posted two-day gains of $3.61 (73%). ...